Cargando…
Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
Marburg virus (MARV) is the causative agent of hemorrhagic fever outbreaks with high case fatality rates. Closely related to Ebola virus, MARV is a filamentous virus with a negative-sense, single-stranded RNA genome. Although extensive studies on filovirus countermeasures have been conducted, there...
Autores principales: | Marzi, Andrea, Menicucci, Andrea R., Engelmann, Flora, Callison, Julie, Horne, Eva J., Feldmann, Friederike, Jankeel, Allen, Feldmann, Heinz, Messaoudi, Ilhem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350103/ https://www.ncbi.nlm.nih.gov/pubmed/30723475 http://dx.doi.org/10.3389/fimmu.2018.03071 |
Ejemplares similares
-
Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease
por: Marzi, Andrea, et al.
Publicado: (2021) -
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019) -
Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017) -
A VSV-based Zika virus vaccine protects mice from lethal challenge
por: Emanuel, Jackson, et al.
Publicado: (2018) -
Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)